AADI Key Statistics, Chart & Performance
The current stock price of AADI is 2.05 USD. In the past month the price decreased by -24.07%. In the past year, price decreased by -5.96%.
AADI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 24.34 | 406.46B | ||
| AMGN | AMGEN INC | 15.22 | 179.28B | ||
| GILD | GILEAD SCIENCES INC | 15.23 | 154.71B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 26.66 | 117.45B | ||
| REGN | REGENERON PHARMACEUTICALS | 17.44 | 82.50B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 785.47 | 52.92B | ||
| INSM | INSMED INC | N/A | 37.94B | ||
| NTRA | NATERA INC | N/A | 32.26B | ||
| BIIB | BIOGEN INC | 10.58 | 25.98B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.22 | 21.84B | ||
| INCY | INCYTE CORP | 15.59 | 19.65B | ||
| EXAS | EXACT SCIENCES CORP | N/A | 19.27B |
Related stock screener links
About AADI
Company Profile
Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Pacific Palisades, California and currently employs 53 full-time employees. The company went IPO on 2018-06-26. The firm is focused on applying technology to deliver improved precision oncology therapies for people living with difficult-to-treat cancers.
Company Info
AADI BIOSCIENCE INC
17383 Sunset Avenue, Suite A250
Pacific Palisades CALIFORNIA US
CEO: Joseph Gardner
Employees: 53
Phone: 14244738055
AADI BIOSCIENCE INC / AADI FAQ
What does AADI BIOSCIENCE INC do?
Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Pacific Palisades, California and currently employs 53 full-time employees. The company went IPO on 2018-06-26. The firm is focused on applying technology to deliver improved precision oncology therapies for people living with difficult-to-treat cancers.
Can you provide the latest stock price for AADI BIOSCIENCE INC?
The current stock price of AADI is 2.05 USD. The price decreased by -2.38% in the last trading session.
Does AADI stock pay dividends?
AADI does not pay a dividend.
What is the ChartMill technical and fundamental rating of AADI stock?
AADI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is AADI BIOSCIENCE INC worth?
AADI BIOSCIENCE INC (AADI) has a market capitalization of 94.85M USD. This makes AADI a Micro Cap stock.
What is the next earnings date for AADI stock?
AADI BIOSCIENCE INC (AADI) will report earnings on 2025-05-06, before the market open.
AADI Technical Analysis
AADI Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AADI. The financial health of AADI is average, but there are quite some concerns on its profitability.
AADI Financial Highlights
Over the last trailing twelve months AADI reported a non-GAAP Earnings per Share(EPS) of -2.35. The EPS increased by 3.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -71.98% | ||
| ROE | -89.57% | ||
| Debt/Equity | 0 |
AADI Forecast & Estimates
8 analysts have analysed AADI and the average price target is 3.06 USD. This implies a price increase of 49.27% is expected in the next year compared to the current price of 2.05.
For the next year, analysts expect an EPS growth of 71.14% and a revenue growth -46.53% for AADI